• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Emergent BioSolutions, Inc. (EBS)

    -NYSE
    27.93 Up 0.29(1.05%) Dec 26, 4:01PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 312,745   281,888   273,384  
    Cost of Revenue62,127  46,077  42,171  
    Gross Profit 250,618   235,811   231,213  
    Operating Expenses
    Research Development119,933  120,226  124,832  
    Selling General and Administrative87,883  76,018  74,282  
    Non Recurring -  9,600   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 42,802   29,967   32,099  
    Income from Continuing Operations
    Total Other Income/Expenses Net565  2,104  (156)
    Earnings Before Interest And Taxes43,367  32,071  31,943  
    Interest Expense -  6   -  
    Income Before Tax43,367  32,065  31,943  
    Income Tax Expense13,108  13,922  15,830  
    Minority Interest876  5,381  6,906  
    Net Income From Continuing Ops31,135  23,524  23,019  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 31,135   23,524   23,019  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 31,135   23,524   23,019  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.